Form 4: Vanda Pharmaceuticals SVP & General Counsel Reports Tax-Related Stock Disposal
SEC Form 4 Filing
Timothy Williams, SVP & General Counsel of Vanda Pharmaceuticals, reports the disposal of shares to cover tax obligations related to vested RSUs.
Summary
- On March 1, 2025, Timothy Williams, SVP & General Counsel of Vanda Pharmaceuticals, disposed of 26,941 shares of common stock to satisfy tax withholding obligations.
- The shares were withheld at a price of $4.76 per share.
- Following the transaction, Williams directly owns 294,884 shares of Vanda Pharmaceuticals.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock transactions for tax purposes, and does not indicate any significant positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders. This transaction is related to tax obligations, which is a common reason for stock disposals by executives.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine disposal of shares for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 03/01/2025 | Date of transaction: Disposal of shares for tax withholding. |
| 03/04/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.